Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

Tablet administered orally, per protocol, 2 x daily. Darolutamide is an orally administered molecular drug therapy that blocks the action of testosterone, the male sex hormone which can stimulate growth of prostate cancer.

"Tablet administered orally, per protocol, 2 x daily. Abemaciclib is an orally administered molecular drug therapy that is called a CDK4/6 inhibitor. CDK4 and CDK6 are enzymes that are involved in helping healthy and cancerous cells divide and blocking these enzymes can stop cancerous cells from growing."

Administered via intramuscular injection, per standard of care. GnRH agonist is a hormonal therapy drug.

Administered via subcutaneous injection, per standard of care. GnRH agonist is a hormonal therapy drug.

Administered via subcutaneous injection, per standard of care. GnRH antagonist is a hormonal therapy drug.